...
首页> 外文期刊>Journal of pediatric urology >Early transplantation into a vesicostomy: a safe approach for managing patients with severe obstructive lesions who are not candidates for bladder augmentation
【24h】

Early transplantation into a vesicostomy: a safe approach for managing patients with severe obstructive lesions who are not candidates for bladder augmentation

机译:早期移植到叶柄术:一种安全方法,用于管理严重阻塞性病变的患者,该病变不是膀胱增强的候选人

获取原文
获取原文并翻译 | 示例
           

摘要

IntroductionManagement of severe antenatally detected oligohydramnios with and without obstruction is improving with the result that more fetuses are surviving with early renal failure. Significant advances have occurred in all specialties involved in the management of these patients. All these specialties working together have resulted in the survival of more patients born with renal failure. ObjectiveThe aim of this study is to highlight the medical advances in antenatal management of fetal oligohydramnios and pulmonary hypoplasia and to demonstrate that transplantation into a diverted urinary system is safe and leads to good outcomes. Study designA case series of five patients were presented who, at the study center's respective facilities, recently underwent renal transplantation into bladders drained by cutaneous vesicostomy after extensive bladder evaluation and whose clinical cases highlight the aim of this study. ResultsA total of 5 patients were reviewed. Renal failure was caused by posterior urethral valves in four patients, and in one patient Eagle-Barrett syndrome. One patient received an amnio-infusion and attempted antenatal bladder shunt. One patient was ventilator dependent until 24 months, and required a tracheostomy, while two patients were ventilator dependent for the first few months of life. Three of five patients were dialysis dependent. Patient age at transplantation ranged from 20 to 61 months. All patients were poorly compliant pre-transplant and had bladder capacities ranging from 10 mL to 72 mL. Months since follow-up ranged from 3 to 64 months. Creatinine levels prior to transplant ranged from 1.9 to 5.6. During the follow up period, this range decreased to 0.13 to 0.53. Two of five patients had UTI episodes since transplantation. Patient A showed Banff Type 1A acute T-cell mediated rejected approximately two months after transplant, but subsequent biopsies have been negative for rejection. Patient A also required a vesicostomy revision approximately two months after transplant and balloon dilation of UVJ anastomosis three months after transplant. DiscussionVesicostomy is an especially attractive option to manage children with small bladders to accommodate the high urinary output that occurs after transplantation in infants who require an adult kidney. Recent advances in antenatal management such as amnioinfusion for oligohydramnios have made significant impacts in pulmonary and renal management of this patient population over recent years. ConclusionThis report provides further support for the use of vesicostomy as an option for surgical management of patients with renal failure with oligohydramnios and severe obstructive lesions identified antenatally. It also indicates the need to update the criteria for antenatal management of oligohydramnios in obstructive and anephric patients.CriteriaABCDECause of renal failurePosterior urethral valvesEagle-Barrett syndromePosterior urethral valvesPosterior urethral valvesPosterior urethral valvesAntenatal interventionsAmnioinfusions; attempted bladder shuntNoneNoneNoneNonePulmonary hypoplasia/ventilator dependencyYes, ventilator dependence until 24 months, requiring tracheostomyVentilator dependence for the first few months of lifeNoneYes, ventilator dependence for first few months of lifeNoneDialysis dependencyYes, was on peritoneal dialysis until transplantationNoNoYes, peritoneal dialysisYes, peritoneal dialysisAge at transplantation to diverted vesicostomy20 months24 months26 months46 months61 monthsPretransplant bladder capacity and compliance30?ml; poorly compliant45?ml; poorly compliant10?ml; poorly compliant72?ml; poorly compliant26?ml; poor complianceFollow-up in months since transplantation12 months12 months3 months16 months64 monthsCreatinine before transplantation3.6–5.62.2–3.31.9–2.84.083.2–3.7Creatinine range during follow-up period0.17–0.360.13–0.380.17–0.340.350.30–0.53Episodes of UTI since transplantationYes, multipleNoneYes,E
机译:严重的破坏检测到的寡酒少杂烩的引入管理随着梗阻的结果正在提高,早期肾功能衰竭的胎儿产生更多的胎儿。所有参与这些患者管理的特色会发生重大进展。所有这些专业共同努力导致更多患者出生的肾功能衰竭的生存。本研究的目的是突出胎儿寡盐胺和肺发育不全的产前管理的医学进展,并证明移植到转向泌尿系统中是安全的,导致良好的结果。研究Designa案例系列五个患者均介绍了在学习中心的各自设施,最近在广泛的膀胱评估后通过皮肤病患者造成的肾移植到肾脏移植中,其临床案件突出了这项研究的目的。结果综述了5例患者。肾功能衰竭是由四名患者中的后尿道阀引起的,并在一名患者鹰 - 巴里特综合征中引起。一名患者接受了羊膜输注和尝试的产前膀胱分流。一名患者依赖于24个月的呼吸机,并且需要一个气管造口术,而两名患者依赖于生命的前几个月的呼吸机。五名患者中的三种依赖于透析。移植的患者年龄范围为20至61个月。所有患者均符合柔顺的预移植性,并且膀胱容量范围为10mL至72ml。随访时间范围为3至64个月。移植前的肌酐水平范围为1.9至5.6。在随访期间,该范围降至0.13至0.53。五个患者中的两种患者以来患有UTI剧集。患者A显示的班夫1A型急性T细胞介导移植后约两个月后被拒绝,但随后的活组织检查对于排斥是阴性的。患者A还需要在移植到阅后三个月后约两个月后约两个月的修复术后三个月。讨论是一种特别有吸引力的选择小膀胱的儿童,以适应需要成年肾脏移植后发生的高尿的输出。产前管理的最新进展,如羊膜胺,少年血液灌注对该患者人口的肺部和肾脏管理对近年来的影响显着。结论该报告还提供了进一步支持使用患者作为肾小球症患者手术管理的选择,并鉴定出直发寡酒醛酸的患者和严重的阻塞性病变。它还表明需要更新阻塞性和无耳疗患者中寡酒酰胺的产前管理的标准。肾功能衰竭尿道尿道术尿道尿道Valveseagle-barrett综合症尿道尿道尿道尿道valvesalantenatoral snoverionsamnioInfusions;膀胱膀胱膀胱肾上腺素奈良酮肿瘤瓣抑制率,呼吸机依赖,止血剂依赖于24个月,需要气管苗血丝依赖于终身的前几个月,呼吸机依赖于寿命依赖于腹膜透析,直至移植透析,腹膜透析,移植腹膜透析术治疗转向vesicostomy20月24个月26个月46个月61个月份前列膀胱容量和合规30?ml;符合良差45?ml;符合差的10?ml;符合不好的72?ml;符合不好的26?ml;在几个月内差的差异差,自移植12月12日期3月164月64日期前60.6-5.62.2-3.31.9-2.84.083.2-3.7CroTeatinine范围0.17-0.360.13-0.380.17-0.340自移植,多平板,e

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号